The increase in systemic TLR4 agonists such as oxidized lipoproteins and phospholipids, heat shock proteins, extracellular matrix protein, and many other molecules secreted during COVID-19 can act as PAMPs for TLR4 and contribute to further damage the host brain parenchyma. Here, TLR4 is linked to COVID-19.